This content is from: Home

UK needs clarity on Swiss-style claims

Actavis UK v Merck & Co, Inc is a recent example of inconsistency between English courts and the European Patent Office regarding second medical use claims. Nigel Jones and Frederick Ch’en of Linklaters discuss its implications

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | One Week Trial